Serum Institute of India (SII) is expanding its vaccine business in the United Kingdom with an investment of £240 million. The serum has already started phase one trials in the UK of a one-dose nasal vaccine for coronavirus, in partnership with Codagenix INC. This was a part of the £533 million of new Indian investment in the UK in growing sectors such as health and technology.
Buy Prime Test Series for all Banking, SSC, Insurance & other exams
Serum’s investment will support clinical trials, research & development and possibly manufacturing of vaccines. This will help the UK and the world to defeat the coronavirus pandemic and other deadly diseases.
Important takeaways for all competitive exams:
The Union Minister for Education, Dharmendra Pradhan, along with Minister of Labour and Employment, Youth…
On 22nd November evening, Jay Shah, the ICC president-elect and current chief of the BCCI…
The Reserve Bank of India (RBI) has raised the transaction limit for UPI 123Pay from…
Many countries around the world are known by special names that reflect their unique identity,…
The Indian Space Research Organisation (ISRO) has entered into a significant collaboration with the Australian…
A potential cyclone named 'Fengal,' suggested by Saudi Arabia, is forming in the Bay of…